DSM completes acquisition of PTG
Royal DSM N.V. announced that it has closed the acquisition of The Polymer Technology Group, Inc. (PTG). Through this acquisition DSM gains a global leading position in the fast growing biomedical materials market. PTG will now be known as DSM PTG. The acquisition was announced on 28 April 2008.
Steve Hartig, President DSM Biomedical, commented: "We are excited that our acquisition of PTG has closed and look forward to moving forward with a combined effort. With PTG, DSM obtains a leading position in the field of biomedical polymers. This acquisition will enable us to grow a unique portfolio of materials-based technologies for the healthcare market. This will allow acceleration in our business growth and market presence."
Bob Ward, President and one of the founders of PTG: "We see the combination of PTG and DSM's biomedical activities as a huge step allowing us to better serve our customers in the medical device and pharmaceutical industries by bringing a much greater breadth of products, technology and services to bear."
The DSM Biomedical and PTG organization will be closely linked to best service the global market. To secure a smooth integration Bob Ward will stay on as President of DSM PTG.
Other news from the department business & finance
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
Spinsolve Benchtop NMR by Magritek
Spinsolve Benchtop NMR
Spinsolve is a revolutionary multinuclear NMR spectrometer that provides the best performance
HYPERION II by Bruker
FT-IR and IR laser imaging (QCL) microscope for research and development
Analyze macroscopic samples with microscopic resolution (5 µm) in seconds
